Ya‐Chin Hou

963 total citations
21 papers, 508 citations indexed

About

Ya‐Chin Hou is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ya‐Chin Hou has authored 21 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Ya‐Chin Hou's work include Pancreatic and Hepatic Oncology Research (5 papers), Immune cells in cancer (5 papers) and Mesenchymal stem cell research (3 papers). Ya‐Chin Hou is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Immune cells in cancer (5 papers) and Mesenchymal stem cell research (3 papers). Ya‐Chin Hou collaborates with scholars based in Taiwan. Ya‐Chin Hou's co-authors include Yan‐Shen Shan, Hao‐Chen Wang, Ying‐Jui Chao, Chih‐Jung Wang, Chia‐Jui Yen, Yan-Shen Shan, Yi‐Ching Wang, Chi–Rong Li, Chung‐Chi Hsu and Wei‐Yu Chen and has published in prestigious journals such as Cancer, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Ya‐Chin Hou

19 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ya‐Chin Hou Taiwan 12 262 199 133 109 84 21 508
Dimpi Mukhopadhyay United States 7 282 1.1× 124 0.6× 83 0.6× 114 1.0× 45 0.5× 11 438
Maria C. Cuitiño United States 9 240 0.9× 186 0.9× 59 0.4× 75 0.7× 77 0.9× 16 445
Αναστασία Κοττόρου Greece 15 245 0.9× 172 0.9× 91 0.7× 175 1.6× 33 0.4× 37 510
Edith Renaud-Gabardos France 11 224 0.9× 120 0.6× 52 0.4× 102 0.9× 46 0.5× 12 416
Maria Chiara Anania Italy 12 258 1.0× 142 0.7× 96 0.7× 108 1.0× 41 0.5× 15 558
Nils L. Visser Netherlands 12 281 1.1× 168 0.8× 114 0.9× 83 0.8× 39 0.5× 13 620
Kaushal Asrani United States 12 227 0.9× 114 0.6× 53 0.4× 117 1.1× 57 0.7× 17 408
Zahra Kadri France 13 278 1.1× 137 0.7× 63 0.5× 105 1.0× 117 1.4× 18 537
Guojun Qu China 6 356 1.4× 216 1.1× 113 0.8× 108 1.0× 17 0.2× 7 521
Ilsa Coleman United States 5 203 0.8× 116 0.6× 99 0.7× 70 0.6× 182 2.2× 7 433

Countries citing papers authored by Ya‐Chin Hou

Since Specialization
Citations

This map shows the geographic impact of Ya‐Chin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Chin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Chin Hou more than expected).

Fields of papers citing papers by Ya‐Chin Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Chin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Chin Hou. The network helps show where Ya‐Chin Hou may publish in the future.

Co-authorship network of co-authors of Ya‐Chin Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Chin Hou. A scholar is included among the top collaborators of Ya‐Chin Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Chin Hou. Ya‐Chin Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuo, Tzu‐Lei, Ya‐Chin Hou, Yan‐Shen Shan, Li‐Tzong Chen, & Wen‐Chun Hung. (2025). Arid1a deficiency sensitises pancreatic cancer to fatty acid synthase inhibition. Clinical and Translational Medicine. 15(7). e70394–e70394.
2.
Wang, Chu-An, Ting‐Yuan Tu, Ya‐Chin Hou, et al.. (2025). Melanophilin-induced primary cilia promote pancreatic cancer metastasis. Cell Death and Disease. 16(1). 22–22. 2 indexed citations
3.
Chang, Chih‐Han, Po-Hsien Huang, Ya‐Chin Hou, et al.. (2025). Macrophage activation determines muscle wasting in pancreatic cancer. Oncogene. 44(32). 2797–2813.
4.
Wang, Hao‐Chen, et al.. (2024). Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment. Molecular Cancer Therapeutics. 23(10). 1431–1445. 7 indexed citations
5.
Wang, Hao‐Chen, et al.. (2024). CD204-positive M2-like tumor-associated macrophages increase migration of gastric cancer cells by upregulating miR-210 to reduce NTN4 expression. Cancer Immunology Immunotherapy. 73(1). 1–1. 5 indexed citations
6.
Chen, Ching‐Yu, Minhua Yu, Ya‐Chin Hou, et al.. (2024). Fully human chitinase-3 like-1 monoclonal antibody inhibits tumor growth, fibrosis, angiogenesis, and immune cell remodeling in lung, pancreatic, and colorectal cancers. Biomedicine & Pharmacotherapy. 176. 116825–116825. 7 indexed citations
7.
Lin, Yu‐Chun, Ya‐Chin Hou, Hao‐Chen Wang, & Yan‐Shen Shan. (2023). New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets. Theranostics. 13(12). 3925–3942. 10 indexed citations
8.
Wang, Hao‐Chen, Chih‐Jung Wang, Ying‐Jui Chao, et al.. (2022). Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling. Journal of Biomedical Science. 29(1). 99–99. 49 indexed citations
9.
Ding, Li-Yun, Chien‐Hung Yu, Hsin‐Yi Wu, et al.. (2022). RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer. Oncogene. 41(22). 3162–3176. 42 indexed citations
10.
Chiang, Nai‐Jung, Ya‐Chin Hou, Kien Thiam Tan, et al.. (2022). The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma. Hepatology International. 16(5). 1137–1149. 14 indexed citations
11.
Hou, Ya‐Chin, Chien‐Yu Chen, Chih‐Jung Wang, et al.. (2022). The Differential Clinical Impacts of Cachexia and Sarcopenia on the Prognosis of Advanced Pancreatic Cancer. Cancers. 14(13). 3137–3137. 21 indexed citations
12.
Hou, Ya‐Chin, Pei‐Yi Chu, Yung‐Yeh Su, et al.. (2022). Semaphorin 6C Suppresses Proliferation of Pancreatic Cancer Cells via Inhibition of the AKT/GSK3/β-Catenin/Cyclin D1 Pathway. International Journal of Molecular Sciences. 23(5). 2608–2608. 11 indexed citations
13.
Yu, Minhua, Ya‐Chin Hou, Chih‐Peng Chang, et al.. (2021). Targeting protumor factor chitinase-3-like-1 secreted by Rab37 vesicles for cancer immunotherapy. Theranostics. 12(1). 340–361. 35 indexed citations
14.
Ding, Li-Yun, Ya‐Chin Hou, I‐Ying Kuo, et al.. (2020). Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer. Clinical Epigenetics. 12(1). 87–87. 13 indexed citations
15.
Hsu, Chung‐Chi, Wen‐Ying Liao, Tze‐Sian Chan, et al.. (2019). The differential distributions of ASPM isoforms and their roles in Wnt signaling, cell cycle progression, and pancreatic cancer prognosis. The Journal of Pathology. 249(4). 498–508. 39 indexed citations
16.
Hou, Ya‐Chin, et al.. (2018). Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes. Journal of Clinical Medicine. 7(12). 502–502. 83 indexed citations
17.
Wang, Hao‐Chen, et al.. (2017). Tumor-Associated Macrophages Promote Epigenetic Silencing of Gelsolin through DNA Methyltransferase 1 in Gastric Cancer Cells. Cancer Immunology Research. 5(10). 885–897. 71 indexed citations
18.
Wang, Hao‐Chen, et al.. (2015). Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine. Pancreatology. 15(3). S18–S19. 4 indexed citations
19.
Hou, Ya‐Chin, et al.. (2015). Therapeutic Efficacy of Spleen-Derived Mesenchymal Stem Cells in Mice with Acute Pancreatitis. Journal of Stem Cell Research & Therapy. 5(12). 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dimpi Mukhopadhyay Breakdown of academic impact, for papers by Maria C. Cuitiño Breakdown of academic impact, for papers by Αναστασία Κοττόρου Breakdown of academic impact, for papers by Edith Renaud-Gabardos Breakdown of academic impact, for papers by Maria Chiara Anania Breakdown of academic impact, for papers by Nils L. Visser Breakdown of academic impact, for papers by Kaushal Asrani Breakdown of academic impact, for papers by Zahra Kadri Breakdown of academic impact, for papers by Guojun Qu Breakdown of academic impact, for papers by Ilsa Coleman
Rankless by CCL
2026